Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line
2006
Combining Genistein with SB715992 Enhances Anti-Cancer Effects in Prostate Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): David A. Davis, Sarah H. Sarkar, Maha Hussain, Yiwei Li, Fazlul H. Sarkar
Primary Institution: Wayne State University School of Medicine
Hypothesis
Can the anti-mitotic inhibitor SB715992's effects on prostate cancer cells be enhanced by the addition of genistein?
Conclusion
SB715992 is a potent anti-tumor agent whose therapeutic effects could be enhanced by genistein.
Supporting Evidence
- SB715992 inhibited cell proliferation and induced apoptosis in PC-3 cells.
- Combination treatment with SB715992 and genistein caused significantly greater cell growth inhibition compared to either agent alone.
- Genistein increased the growth inhibitory effects of SB715992 on PC-3 cells.
Takeaway
This study found that a new cancer drug, SB715992, works better when combined with a natural substance called genistein, which comes from soy.
Methodology
PC-3 cells were treated with SB715992 and genistein, followed by assays for cell proliferation, apoptosis, and gene expression analysis.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website